James L. Rubenstein, M.D., Ph.D.
Affiliations: | Medicine | University of California, San Francisco, San Francisco, CA |
Area:
CNS Lymphoma, Multiple MyelomaWebsite:
http://cancer.ucsf.edu/people/profiles/rubenstein_james.3645Google:
"James Rubenstein"Mean distance: 17.11 (cluster 6)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Batchelor TT, Giri S, Ruppert AS, et al. (2024) Myeloablative Vs. Non-Myeloablative Consolidation for Primary Central Nervous System Lymphoma: Results of Alliance 51101. Blood Advances |
| David KA, Sundaram S, Kim SH, et al. (2023) Older Patients with Primary Central Nervous System Lymphoma: Survival and Prognostication Across 20 US Cancer Centers. American Journal of Hematology |
| Wu SY, Braunstein SE, Rubenstein JL, et al. (2023) Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma. Cureus. 15: e34817 |
| Goyal V, Salmasi G, Leavitt AD, et al. (2022) Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report. Ejhaem. 3: 1000-1002 |
| Chan JP, Merlini M, Gao HX, et al. (2021) Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell Lymphoma. The American Journal of Pathology. 191: 575-583 |
| Wu CH, Yang CY, Wang L, et al. (2020) Cutaneous T cell lymphoma PDX drug screening platform identifies cooperation between inhibitions of PI3Kα/δ and HDAC. The Journal of Investigative Dermatology |
| Tsang M, Cleveland J, Rubenstein JL. (2020) On Point in Primary CNS Lymphoma. Hematological Oncology |
| Batchelor T, Giri S, Ruppert AS, et al. (2020) Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of induction therapy in Alliance 51101. Journal of Clinical Oncology. 38: 8042-8042 |
| Ferreri AJM, Holdhoff M, Nayak L, et al. (2019) Evolving Treatments for Primary Central Nervous System Lymphoma. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 454-466 |
| Rubenstein JL, Geng H, Vu K, et al. (2019) Maintenance Lenalidomide in Primary CNS Lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology |